Nicholas A. Shackel, Geoffrey W. McCaughan, Fiona J. Warner – 28 May 2008

Vicente Arroyo, Javier Fernandez, Antoni Mas, Angels Escorsell – 28 May 2008

28 May 2008

Daniel Benten, Martina Sterneck, Jens Panse, Xavier Rogiers, Ansgar W. Lohse – 28 May 2008 – The incidence of de novo malignancies is increased in organ transplant recipients, and patients with hepatic carcinomas are at high risk for tumor recurrence after liver transplantation. Data about recurrent cancer after orthotopic liver transplantation (OLT) in patients with a history of nonhepatic malignancy are very limited. We retrospectively analyzed data from 606 adult OLT recipients and identified 37 patients (6.1%) with a preexisting extrahepatic malignancy.

Moshe Israeli, Tirza Klein, Benjamin Sredni, Yaron Avitzur, Eitan Mor, Nathan Bar‐Nathen, Ran Steinberg, Gabriel Dinari, Rivka Shapiro – 28 May 2008 – Lifelong immunosuppression is mandatory for optimal graft and patient survival following liver transplantation. Nevertheless, graft rejection or numerous adverse events associated with overimmunosuppression or underimmunosuppression cannot be completely avoided. The ImmuKnow assay measures cell‐mediated immunity and is able to discern between conditions of overimmunosuppression and underimmunosuppression.

Shin Hwang, Sung‐Gyu Lee, Chul‐Soo Ahn, Ki‐Hun Kim, Deok‐Bog Moon, Tae‐Yong Ha, Gi‐Won Song, Dong‐Hwan Jung, Jung‐Ik Park, Je‐Ho Ryu, Hyo‐Jun Lee, Dong‐Jin Suh, Young‐Suk Lim – 28 May 2008 – The prevention of hepatitis B virus (HBV) recurrence is essential after liver transplantation in patients infected with HBV. We evaluated the efficacy of primary high‐dose hepatitis B immunoglobulin (HBIG) monotherapy and rescue antiviral therapy in 639 HBV‐infected adult patients who underwent living donor liver transplantation (LDLT) between February 1997 and December 2004.

Kun L. Ma, Xiong Z. Ruan, Stephen H. Powis, Yaxi Chen, John F. Moorhead, Zac Varghese – 27 May 2008 – The prevailing theory in non‐alcoholic fatty liver disease (NAFLD) is the “two‐hit” hypothesis. The first hit mainly consists of lipid accumulation, and the second is subsequent systemic inflammation. The current study was undertaken to investigate whether inflammatory stress exacerbates lipid accumulation in liver and its underlying mechanisms.

Andrew D. Yeoman, Thawab Al‐Chalabi, John B. Karani, Alberto Quaglia, John Devlin, Giorgina Mieli‐Vergani, Adrian Bomford, John G. O'Grady, Phillip M. Harrison, Michael A. Heneghan – 27 May 2008 – Hepatocellular carcinoma (HCC) has traditionally been considered a rare complication of cirrhosis secondary to autoimmune hepatitis (AIH), yet the true incidence remains unknown due to a lack of published data. Consequently, some professional guidelines do not mandate routine surveillance for HCC in this condition.

Pavel Strnad, Guo‐Zhong Tao, Phillip So, Kenneth Lau, Jim Schilling, Yuquan Wei, Jian Liao, M. Bishr Omary – 27 May 2008 – The cytoplasmic hepatocyte inclusions, Mallory‐Denk bodies (MDBs), are characteristic of several liver disorders, including alcoholic and nonalcoholic steatohepatitis. In mice, MDBs can be induced by long‐term feeding with 3,5‐diethoxycarbonyl‐1,4‐dihydrocollidine (DDC) for 3 to 4 months or rapidly reformed in DDC‐induced then recovered mice by DDC refeeding or exposure to a wide range of toxins for only 5 to 7 days.

Sara Crumm, Montserrat Cofan, Egle Juskeviciute, Jan B. Hoek – 27 May 2008 – Liver regeneration after partial hepatectomy (PHx) is orchestrated by multiple signals from cytokines and growth factors. We investigated whether increased energy demand on the remnant liver after PHx contributes to regenerative signals. Changes in the tissue's energy state were determined from adenine nucleotide levels.